Renate K. Hukema
Rotterdam, ZH 3015GD, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Modelling fragile X-associated neuropsychiatric disorders in young inducible 90CGG premutation mice.
Modelling fragile X-associated neuropsychiatric disorders in young inducible 90CGG premutation mice.
Journal: Brain : a journal of neurology
Published: December 25, 2024
Implementing Advance Care Planning and Care Coordination in the Care for People With Parkinson Disease: A Feasibility Study.
Journal: The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses
Published: August 16, 2024
Editorial: Proceedings of the "Fourth International Conference of the FMR1 Premutation: Basic Mechanisms, Clinical Involvement and Therapy".
Journal: Frontiers in molecular biosciences
Published: February 24, 2021
Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation.
Journal: Human molecular genetics
Published: September 10, 2020
Lack of a Clear Behavioral Phenotype in an Inducible FXTAS Mouse Model Despite the Presence of Neuronal FMRpolyG-Positive Aggregates.
Journal: Frontiers in molecular biosciences
Published: August 26, 2020
Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms.
Journal: Brain communications
Published: June 26, 2020
Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice.
Journal: Disease models & mechanisms
Published: March 09, 2020
Short antisense oligonucleotides alleviate the pleiotropic toxicity of RNA harboring expanded CGG repeats.
Journal: Nature communications
Published: December 23, 2019
In silico, in vitro, and in vivo Approaches to Identify Molecular Players in Fragile X Tremor and Ataxia Syndrome.
Journal: Frontiers in molecular biosciences
Published: November 22, 2019
Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS.
Reduction of Fmr1 mRNA Levels Rescues Pathological Features in Cortical Neurons in a Model of FXTAS.
Journal: Molecular therapy. Nucleic acids
Published: July 18, 2019
Refining the Spectrum of Neuronal Intranuclear Inclusion Disease: A Case Report.
Journal: Journal of neuropathology and experimental neurology
Published: June 01, 2019
Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology.
Journal: Acta neuropathologica communications
Published: February 08, 2019
Last Updated: 09/26/2026